Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 65 of 175 for:    pertuzumab

Evaluation of Trastuzumab in Combination With Lapatinib or Pertuzumab in Combination With Trastuzumab-Emtansine to Treat Patients With HER2-positive Metastatic Colorectal Cancer (HERACLES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03225937
Recruitment Status : Active, not recruiting
First Posted : July 21, 2017
Last Update Posted : October 30, 2018
Information provided by (Responsible Party):
Fondazione del Piemonte per l'Oncologia

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : June 2019